Altium Capital Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-370,000
| Closed | -$4.89M | – | 57 |
|
2024
Q4 | $4.89M | Buy |
+370,000
| New | +$4.89M | 1.39% | 26 |
|
2021
Q4 | – | Sell |
-108,000
| Closed | -$2.06M | – | 153 |
|
2021
Q3 | $2.06M | Buy |
+108,000
| New | +$2.06M | 0.54% | 69 |
|
2021
Q2 | – | Sell |
-253,448
| Closed | -$5.67M | – | 151 |
|
2021
Q1 | $5.67M | Sell |
253,448
-10,148
| -4% | -$227K | 1.57% | 11 |
|
2020
Q4 | $5.86M | Buy |
+263,596
| New | +$5.86M | 2.19% | 6 |
|